Due to the high number of COVID-19 patients and the economic, physical, and psychological burden of reproductive and fertility diseases, we decided to investigate the effect of the COVID-19 virus on menstrual disorders and AMH, TPO, thyroid stimulating hormone (TSH) and prolactin levels in women with the COVID-19 disease. This evidence concerns the gene PRL and Menstrual disorder.